Lifecore Biomedical, Inc. LFCR Derivative Liabilities (Non-Current)
Derivative Liabilities (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesNoncurrent.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s derivative liabilities (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s derivative liabilities (non-current)?
- Lifecore Biomedical, Inc. (LFCR) reported derivative liabilities (non-current) of $29.72M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s derivative liabilities (non-current) changed year-over-year?
- Lifecore Biomedical, Inc.'s derivative liabilities (non-current) increased by 18.9% year-over-year, from $24.99M to $29.72M.
- What does derivative liabilities (non-current) mean?
- This metric represents the fair value of financial derivative instruments that are classified as long-term liabilities on the balance sheet. These obligations arise from contracts such as warrants, options, or embedded derivatives that are not expected to be settled within the next twelve months. Monitoring this figure is essential for assessing long-term financial risk and potential future dilution or cash outflows associated with complex financing arrangements.